YBX1 and neoplasm: In addition to data showing worse survival in mice harboring YB1-overexpressing tumors and robust YB1 protein express across all subgroups, the single cell sequencing expression profiles suggest that YB1 inhibition in stem or progenitor-like populations previously implicated in driving relapse could sensitize tumor cells to radiation, resulting in improved therapeutic response.